Hepatitis B Virus Infection and Immunopathogenesis in a Humanized Mouse Model

Induction of Human-Specific Liver Fibrosis and M2-Like Macrophages

Moses T. Bility, Liang Cheng, Zheng Zhang, Yan Luan, Feng Li, Liqun Chi, Liguo Zhang, Zhengkun Tu, Yanhang Gao, Yangxin Fu, Junqi Niu, Fusheng Wang, Lishan Su

Research output: Contribution to journalArticle

96 Citations (Scopus)

Abstract

The mechanisms of chronic HBV infection and immunopathogenesis are poorly understood due to a lack of a robust small animal model. Here we report the development of a humanized mouse model with both human immune system and human liver cells by reconstituting the immunodeficient A2/NSG (NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ mice with human HLA-A2 transgene) with human hematopoietic stem cells and liver progenitor cells (A2/NSG-hu HSC/Hep mice). The A2/NSG-hu HSC/Hep mouse supported HBV infection and approximately 75% of HBV infected mice established persistent infection for at least 4 months. We detected human immune responses, albeit impaired in the liver, chronic liver inflammation and liver fibrosis in infected animals. An HBV neutralizing antibody efficiently inhibited HBV infection and associated liver diseases in humanized mice. In addition, we found that the HBV mediated liver disease was associated with high level of infiltrated human macrophages with M2-like activation phenotype. Importantly, similar M2-like macrophage accumulation was confirmed in chronic hepatitis B patients with liver diseases. Furthermore, gene expression analysis showed that induction of M2-like macrophage in the liver is associated with accelerated liver fibrosis and necrosis in patients with acute HBV-induced liver failure. Lastly, we demonstrate that HBV promotes M2-like activation in both M1 and M2 macrophages in cell culture studies. Our study demonstrates that the A2/NSG-hu HSC/Hep mouse model is valuable in studying HBV infection, human immune responses and associated liver diseases. Furthermore, results from this study suggest a critical role for macrophage polarization in hepatitis B virus-induced immune impairment and liver pathology.

Original languageEnglish (US)
Article numbere1004032
JournalPLoS Pathogens
Volume10
Issue number3
DOIs
StatePublished - Jan 1 2014

Fingerprint

Virus Diseases
Hepatitis B virus
Liver Cirrhosis
Macrophages
varespladib methyl
Liver Diseases
Liver
Infection
HLA-A2 Antigen
Chronic Hepatitis B
Liver Failure
Hematopoietic Stem Cells
Neutralizing Antibodies
Transgenes
Immune System
Necrosis
Stem Cells
Animal Models
Cell Culture Techniques
Pathology

ASJC Scopus subject areas

  • Parasitology
  • Microbiology
  • Immunology
  • Molecular Biology
  • Genetics
  • Virology

Cite this

Hepatitis B Virus Infection and Immunopathogenesis in a Humanized Mouse Model : Induction of Human-Specific Liver Fibrosis and M2-Like Macrophages. / Bility, Moses T.; Cheng, Liang; Zhang, Zheng; Luan, Yan; Li, Feng; Chi, Liqun; Zhang, Liguo; Tu, Zhengkun; Gao, Yanhang; Fu, Yangxin; Niu, Junqi; Wang, Fusheng; Su, Lishan.

In: PLoS Pathogens, Vol. 10, No. 3, e1004032, 01.01.2014.

Research output: Contribution to journalArticle

Bility, MT, Cheng, L, Zhang, Z, Luan, Y, Li, F, Chi, L, Zhang, L, Tu, Z, Gao, Y, Fu, Y, Niu, J, Wang, F & Su, L 2014, 'Hepatitis B Virus Infection and Immunopathogenesis in a Humanized Mouse Model: Induction of Human-Specific Liver Fibrosis and M2-Like Macrophages', PLoS Pathogens, vol. 10, no. 3, e1004032. https://doi.org/10.1371/journal.ppat.1004032
Bility, Moses T. ; Cheng, Liang ; Zhang, Zheng ; Luan, Yan ; Li, Feng ; Chi, Liqun ; Zhang, Liguo ; Tu, Zhengkun ; Gao, Yanhang ; Fu, Yangxin ; Niu, Junqi ; Wang, Fusheng ; Su, Lishan. / Hepatitis B Virus Infection and Immunopathogenesis in a Humanized Mouse Model : Induction of Human-Specific Liver Fibrosis and M2-Like Macrophages. In: PLoS Pathogens. 2014 ; Vol. 10, No. 3.
@article{5bf651f7e73c4406883fab87aa1a18ec,
title = "Hepatitis B Virus Infection and Immunopathogenesis in a Humanized Mouse Model: Induction of Human-Specific Liver Fibrosis and M2-Like Macrophages",
abstract = "The mechanisms of chronic HBV infection and immunopathogenesis are poorly understood due to a lack of a robust small animal model. Here we report the development of a humanized mouse model with both human immune system and human liver cells by reconstituting the immunodeficient A2/NSG (NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ mice with human HLA-A2 transgene) with human hematopoietic stem cells and liver progenitor cells (A2/NSG-hu HSC/Hep mice). The A2/NSG-hu HSC/Hep mouse supported HBV infection and approximately 75{\%} of HBV infected mice established persistent infection for at least 4 months. We detected human immune responses, albeit impaired in the liver, chronic liver inflammation and liver fibrosis in infected animals. An HBV neutralizing antibody efficiently inhibited HBV infection and associated liver diseases in humanized mice. In addition, we found that the HBV mediated liver disease was associated with high level of infiltrated human macrophages with M2-like activation phenotype. Importantly, similar M2-like macrophage accumulation was confirmed in chronic hepatitis B patients with liver diseases. Furthermore, gene expression analysis showed that induction of M2-like macrophage in the liver is associated with accelerated liver fibrosis and necrosis in patients with acute HBV-induced liver failure. Lastly, we demonstrate that HBV promotes M2-like activation in both M1 and M2 macrophages in cell culture studies. Our study demonstrates that the A2/NSG-hu HSC/Hep mouse model is valuable in studying HBV infection, human immune responses and associated liver diseases. Furthermore, results from this study suggest a critical role for macrophage polarization in hepatitis B virus-induced immune impairment and liver pathology.",
author = "Bility, {Moses T.} and Liang Cheng and Zheng Zhang and Yan Luan and Feng Li and Liqun Chi and Liguo Zhang and Zhengkun Tu and Yanhang Gao and Yangxin Fu and Junqi Niu and Fusheng Wang and Lishan Su",
year = "2014",
month = "1",
day = "1",
doi = "10.1371/journal.ppat.1004032",
language = "English (US)",
volume = "10",
journal = "PLoS Pathogens",
issn = "1553-7366",
publisher = "Public Library of Science",
number = "3",

}

TY - JOUR

T1 - Hepatitis B Virus Infection and Immunopathogenesis in a Humanized Mouse Model

T2 - Induction of Human-Specific Liver Fibrosis and M2-Like Macrophages

AU - Bility, Moses T.

AU - Cheng, Liang

AU - Zhang, Zheng

AU - Luan, Yan

AU - Li, Feng

AU - Chi, Liqun

AU - Zhang, Liguo

AU - Tu, Zhengkun

AU - Gao, Yanhang

AU - Fu, Yangxin

AU - Niu, Junqi

AU - Wang, Fusheng

AU - Su, Lishan

PY - 2014/1/1

Y1 - 2014/1/1

N2 - The mechanisms of chronic HBV infection and immunopathogenesis are poorly understood due to a lack of a robust small animal model. Here we report the development of a humanized mouse model with both human immune system and human liver cells by reconstituting the immunodeficient A2/NSG (NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ mice with human HLA-A2 transgene) with human hematopoietic stem cells and liver progenitor cells (A2/NSG-hu HSC/Hep mice). The A2/NSG-hu HSC/Hep mouse supported HBV infection and approximately 75% of HBV infected mice established persistent infection for at least 4 months. We detected human immune responses, albeit impaired in the liver, chronic liver inflammation and liver fibrosis in infected animals. An HBV neutralizing antibody efficiently inhibited HBV infection and associated liver diseases in humanized mice. In addition, we found that the HBV mediated liver disease was associated with high level of infiltrated human macrophages with M2-like activation phenotype. Importantly, similar M2-like macrophage accumulation was confirmed in chronic hepatitis B patients with liver diseases. Furthermore, gene expression analysis showed that induction of M2-like macrophage in the liver is associated with accelerated liver fibrosis and necrosis in patients with acute HBV-induced liver failure. Lastly, we demonstrate that HBV promotes M2-like activation in both M1 and M2 macrophages in cell culture studies. Our study demonstrates that the A2/NSG-hu HSC/Hep mouse model is valuable in studying HBV infection, human immune responses and associated liver diseases. Furthermore, results from this study suggest a critical role for macrophage polarization in hepatitis B virus-induced immune impairment and liver pathology.

AB - The mechanisms of chronic HBV infection and immunopathogenesis are poorly understood due to a lack of a robust small animal model. Here we report the development of a humanized mouse model with both human immune system and human liver cells by reconstituting the immunodeficient A2/NSG (NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ mice with human HLA-A2 transgene) with human hematopoietic stem cells and liver progenitor cells (A2/NSG-hu HSC/Hep mice). The A2/NSG-hu HSC/Hep mouse supported HBV infection and approximately 75% of HBV infected mice established persistent infection for at least 4 months. We detected human immune responses, albeit impaired in the liver, chronic liver inflammation and liver fibrosis in infected animals. An HBV neutralizing antibody efficiently inhibited HBV infection and associated liver diseases in humanized mice. In addition, we found that the HBV mediated liver disease was associated with high level of infiltrated human macrophages with M2-like activation phenotype. Importantly, similar M2-like macrophage accumulation was confirmed in chronic hepatitis B patients with liver diseases. Furthermore, gene expression analysis showed that induction of M2-like macrophage in the liver is associated with accelerated liver fibrosis and necrosis in patients with acute HBV-induced liver failure. Lastly, we demonstrate that HBV promotes M2-like activation in both M1 and M2 macrophages in cell culture studies. Our study demonstrates that the A2/NSG-hu HSC/Hep mouse model is valuable in studying HBV infection, human immune responses and associated liver diseases. Furthermore, results from this study suggest a critical role for macrophage polarization in hepatitis B virus-induced immune impairment and liver pathology.

UR - http://www.scopus.com/inward/record.url?scp=84897420281&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84897420281&partnerID=8YFLogxK

U2 - 10.1371/journal.ppat.1004032

DO - 10.1371/journal.ppat.1004032

M3 - Article

VL - 10

JO - PLoS Pathogens

JF - PLoS Pathogens

SN - 1553-7366

IS - 3

M1 - e1004032

ER -